Included Health is partnering with Carrum Health to provide high-quality specialty care while reducing costs for employers. The post Included Health Taps Carrum Health for Value-Based Specialty Care appeared first on MedCity News.
Limbic launches AI-powered CBT under FDA Pilot program
Amylyx Pharmaceuticals’ avexitide led to statistically significant and clinically meaningful reductions in hypoglycemic events in patients with post-bariatric hypoglycemia (PBH). This peptide drug, a GLP-1 antagonist, was acquired from Eiger BioPharmaceuticals in 2024. The post Amylyx Plans FDA Filing After GLP-1 Drug Hits Trial Goals in Rare Metabolic Condition appeared first on MedCity News.
By KIM BELLARD I was amused – oh, I should be polite and say “interested” — to see a new study, led by researchers from Yale School of Public Medicine, about the benefits of a universal single payor health system. It concluded that we could save 100,000 lives annually and save some 1.04 trillion each…
Rural hospitals need trained people, tested backups, downtime procedures, clinical continuity planning, and staff who know what to do when an alert fires. A framework won’t substitute for that work, but it helps organize it and makes progress measurable. The post Rural US Healthcare Has A Cybersecurity Problem — CMS Funding Can Help Fix the…
It had been a rough few months. Cynthia Tompkins was hospitalized in May for osteomyelitis — a bone infection — then spent six weeks in a rehabilitation facility. “It was a struggle,” she said. “I didn’t bounce back too well.” Tompkins returned to her home in San Diego, but she was still taking antibiotics, along…
WHITE MESA, Utah — On a hot April day, Malcolm Lehi maneuvered his Jeep Wrangler over a rough dirt road past junipers and sagebrush in search of Entrance Spring on land long connected to his tribe, the Ute Mountain Ute. The cool, mossy spring lies just across the highway from White Mesa Mill, the nation’s…
KFF found that insurers denied 12%-18% of standard prior authorization requests in 2025, with significant variation among insurers and gaps in transparency. The post KFF: Insurers Denied 12%-18% of Prior Authorization Requests in 2025 appeared first on MedCity News.
Migraine drugs developer Slate Medicines is going public in a reverse merger with Fulcrum Therapeutics. The biotech’s lead antibody drug blocks two novel migraine targets, offering the potential for better efficacy compared to other next-generation migraine drugs in R&D. The post Slate Medicines’ Merger and $245M Private Placement Fuel Mission in Migraine appeared first on…
Consumer diagnostics will be one of several discussions at the INVEST Digital Health conference focused on power shifting to the consumer in healthcare. The conference is scheduled for October 29 in Dallas at Pegasus Park, in partnership with Health Wildcatters. Click here to view the agenda and register. The post The Rise of Consumer Diagnostics…